Kurse werden geladen...
Prognose
| Kaufen | 3 |
| Halten | 0 |
| Verkaufen | 0 |
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
REPEAT/Cybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible Debentures
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American: CYBN) (Cboe Canada: CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce the Company has entered into a securities purchase agreement (the “Securities Purchase Agreement”) with High Trail Special Situations LLC (“High Trail”), pursuant to which the Company agreed to sell a.» Mehr auf businesswire.com
Cybin Reports Fiscal Year 2025 Financial Results and Recent Business Highlights
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe Canada CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, today reported audited financial results for its fiscal year ended March 31, 2025, and recent business highlights. “During the past 12 months, we have continued to focus on building out the strong foundation that underpins.» Mehr auf businesswire.com
Cybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible Debentures
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American: CYBN) (Cboe Canada: CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce the Company has entered into a securities purchase agreement (the “Securities Purchase Agreement”) with High Trail Special Situations LLC (“High Trail”), pursuant to which the Company agreed to sell a.» Mehr auf businesswire.com
Unternehmenszahlen
| (EUR) | März 2025 | |
|---|---|---|
| Umsatz | 0,00 | - |
| Bruttoeinkommen | 0,00 | 100,00% |
| Nettoeinkommen | −19,64 Mio | 34,28% |
| EBITDA | −21,33 Mio | 24,26% |
Fundamentaldaten
| Metrik | Wert |
|---|---|
Marktkapitalisierung | 134,39 Mio€ |
Anzahl Aktien | 21,03 Mio |
52 Wochen-Hoch/Tief | 11,89€ - 4,12€ |
| Dividenden | Nein |
Beta | 1,13 |
KGV (PE Ratio) | −1,95 |
KGWV (PEG Ratio) | −0,05 |
KBV (PB Ratio) | 0,85 |
KUV (PS Ratio) | 0,00 |
Unternehmensprofil
| Name | Cybin Aktie |
| CEO | Douglas L. Drysdale |
| Mitarbeiter | 50 |
Assets entdecken
Shareholder von Cybin Aktie investieren auch in folgende Assets
